a b s t r a c t BACKGROUND: Pleomorphic xanthoastrocytoma (PXA) classified as a low Grade (WHO II) astrocytic neoplasm. It is known for its relatively favorable prognosis. It most commonly occurs in young adults. Malignant progression in PXA has been frequently reported since its first description in 1979; however, the presentation of a primary anaplastic PXA tumor with an aggressive clinical course in adults is rare especially in the later age group. CASE DESCRIPTION: We present a case of primary anaplastic PXA in a 53 year old male that manifested with an early recurrence pattern at 9 weeks. Treatment performed was surgical excision and external beam radiotherapy. The aforementioned tumor followed an aggressive clinical course. Tumor cells exhibited the characteristic expression of GFAP (Glial fibrillary acidic protein), higher proliferative index (8-10%) on Ki-67 staining along with the presence of increased mitoses ( >5/10hpf). A review of previously reported primary anaplastic pleomorphic xanthoastrocytoma cases in adults with histological features was also done. CONCLUSION: Our review of all reported cases of APXA in adults concludes that the clinical behavior of this tumor varies considerably from its benign variant. Early disease recurrence in anaplastic pleomorphic xanthoastrocytomas is associated with fatal outcomes. As per our review of literature it is seen that anaplastic variant of PXA shows histological characteristics as well as clinical course comparable with Grade III astrocytomas.
Introduction
Pleomorphic xanthoastrocytoma (PXA) is an astrocytic neoplasm with a relatively favorable prognosis [8] . According to WHO classification for astrocytic neoplasms, it has been classified histologically as a grade II (benign) neoplasm [6] . The first case was reported in 1979 [11] . It is often superficially located in the cerebral cortex with leptomennigeal involvement. Morphologically it shows a pleomorphic histological appearance that includes lipidized, GFAP-expressing tumor cells with cytoplasmic xanthic change surrounded by a reticulin network [9] . It has been frequently seen that tumors initially diagnosed as PXA have later shown malig-nant progression to high grade astrocytomas (grade III or IV). In these cases the initial histological findings corresponded to a grade II neoplasm; however over the recurrences it was found to be malignant [3] . To the best of our knowledge, only a few cases have been reported in the literature, which demonstrate a PXA tumor presenting with anaplastic features at initial presentation. These cases have been reported mostly in children and young adults ranging between 7-25 years [16] . Here we present a case of a primary anaplastic PXA tumor in the later age group with an unusual early recurrence pattern. We then review the literature of previously reported cases of primary anaplastic PXA tumors in adults.
Case description
55 years old male presented with a history of sudden onset headaches and two episodes of generalized tonic clonic seizures in 3 months. Neurological examination did not show any focal motor or sensory deficits. MRI brain showed a 2. thickening and enhancement along left medial temporal lobe and sylvian fissure. It appeared as a multicystic lesion with peripheral enhancement and marked perilesional oedema (Fig. 1) . MR Spectroscopy showed high choline/creatine and high choline/NAA ratios in the enhancing areas (Fig. 2 ). Patient underwent a left sided pterional craniotomy for excision of the lesion. Gross total resection of the tumor was performed. Immediate post operative MRI scan was not done due to financial constraints. Biopsy report suggested a neoplastic lesion composed of plump spindle-shaped pleomorphic cells having elongated nuclei with eosinophilic cytoplasm and other cells having bizarre pleomorphic nuclei with abundant cytoplasm. GFAP (glial fibrillary acidic protein) immune staining showed diffuse expression in tumor cells.Ki-67 staining showed a proliferative index of upto 8-10% in some areas along with the presence of increased mitoses (>5/10hpf). H & E staining also showed a few xanthomatous cells along with areas of focal necrosis. CD34 immune staining was negative excluding epitheliod cell glioblastoma (Figs. 4 and 5). Overall findings were suggestive of an anaplastic pleomorphic xanthoastrocytoma. Case was discussed in the tumor board meeting and external beam radiotherapy was advised. On follow up visit patient exhibited mild to moderate cognitive impairment, sensory dysphasia and disorientation. MRI scan was repeated 9 weeks after surgery. Repeat scan showed a significant overall increase in tumor size with both multifocal cystic and solid components involving left frontal, temporal and parietal lobes measuring approximately 9.6 × 5.1 × 5 cm clearly elicited disease progression (Fig. 3) . The prognosis of the patient was discussed with family regarding further management plan and it was decided to continue radiotherapy and no surgical intervention was planned. Patient died at 16 weeks from the time of initial diagnosis.
Discussion
PXA with anaplastic features is a rare tumor hence no definitive treatment guidelines have been established so far. The recent consolidated review of literature by Tmara et al. [24] in 2012 has reported 20 cases of primary anaplastic PXA in adults (18 above) so far. We report a total of 24 cases of primary APXA in adults from 1979 to 2016. We describe this case of primary anaplastic PXA in an adult male with special regard to a rapid disease progression only after a 9 weeks interval. To the best of our knowledge only one case of primary anaplastic PXA has been reported to have an earlier recurrence at 1 month (Kim et al., 2009) [12] . The average recurrence interval as per our literature review was approximately 14 months from the time of initial diagnosis. The APXA lesion was found to be mostly located in temporal and parietal lobes in most of the cases. It showed similar pattern involving the medial temporal lobe and para sylvian fissure in the aforementioned case description. Previous studies have shown presence of neuroglial tumor markers like GFAP expression with reticulin deposition as it was seen in this case [23] . Our inference about behavior of PXA as an anaplastic tumor stems from the fact that tumor showed proliferative index of 8-10% in some areas, which along with the presence of increased mitoses (>5/10hpf) corresponded to WHO grade III classification of diffuse astrocytomas [15] . Previously reported cases of APXA also have shown similar histological characteristics (Table 2 ). It was seen that presence of pleomorphism was a consistent feature in majority of the cases. The APXA tissue sections show bizarre giant cells that are multinucleated or have multilobulated nuclei, with intracytoplasmatic lipid-containing vacuoles (xanthic), and are generally organized in alveolar structures, with an abundant surrounding reticulin network and perivascular lymphoid infiltrates. In contrast to benign PXA, the anaplastic variants have consistently shown high mitotic activity along with areas of focal necrosis in most of the cases. Long term control of anaplastic PXA with recurrences has been attributed to postsurgical stereotactic radiation therapy (Koga, Tomoyuki, et al) [13] . However due to its unavailability in our facility we planned to provide external beam radiation therapy for long term palliative control of tumor. According to the current review of literature the most commonly used treatment option was surgical excision and post surgical radiotherapy. Complete surgical excision is still an effective treatment in benign PXA with excellent 5 year and 10 year survival rates; however, we found that gross total resection in APXA is still associated with frequent recurrences. Previously there was no sufficient literature supporting the role of chemotherapy in the treatment of pleomorphic xanthoastrocytomas in adults, recent studies have shown the role of BRAF V600E inhibitors in treatment of PXA tumors pertaining to the high frequency of these mutations in PXA tumors [22] . Due to the lack of BRAFV600E testing in our facility, no chemotherapy was planned for this patient. The average survival in months among the reported APXA cases was approximately 24 months from the time of initial diagnosis according to our case review (Table 1 ). This indicates a relatively poor prognosis in patients with anaplastic PXA tumor at the initial presentation when compared with the benign PXA tumors in adults [19] .
Conclusion
Our review of all reported cases of APXA in adults concludes that the clinical behavior of this tumor varies considerably from its benign variant. As per this review of literature it is seen that anaplastic variant of PXA shows histological characteristics as well as clinical course comparable with Grade III astrocytomas. Early disease recurrence in anaplastic pleomorphic xanthoastrocytomas is associated with fatal outcomes.
We recommend further evaluation of PXA with anaplastic features regarding their genetic characteristics to understand the origin as well as behavior of this tumor. 
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